These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 26804063)

  • 1. Apolipoproteins, lipids and risk of cancer.
    Borgquist S; Butt T; Almgren P; Shiffman D; Stocks T; Orho-Melander M; Manjer J; Melander O
    Int J Cancer; 2016 Jun; 138(11):2648-56. PubMed ID: 26804063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle and Dietary Determinants of Serum Apolipoprotein A1 and Apolipoprotein B Concentrations: Cross-Sectional Analyses within a Swedish Cohort of 24,984 Individuals.
    Frondelius K; Borg M; Ericson U; Borné Y; Melander O; Sonestedt E
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
    Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.
    Gianfagna F; Veronesi G; Guasti L; Chambless LE; Brambilla P; Corrao G; Mancia G; Cesana G; Ferrario MM
    Atherosclerosis; 2014 Sep; 236(1):175-81. PubMed ID: 25062081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of lipids and apolipoproteins in three cultures.
    Solhpour A; Parkhideh S; Sarrafzadegan N; Asgary S; Williams K; Jungner I; Aastveit A; Walldius G; Sniderman A
    Atherosclerosis; 2009 Nov; 207(1):200-7. PubMed ID: 19766218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
    Raitakari OT; Mäkinen VP; McQueen MJ; Niemi J; Juonala M; Jauhiainen M; Salomaa V; Hannuksela ML; Savolainen MJ; Kesäniemi YA; Kovanen PT; Sundvall J; Solakivi T; Loo BM; Marniemi J; Hernesniemi J; Lehtimäki T; Kähönen M; Peltonen M; Leiviskä J; Jula A; Anand SS; Miller R; Yusuf S; Viikari JS; Ala-Korpela M
    Atherosclerosis; 2013 Jan; 226(1):245-51. PubMed ID: 23159013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
    Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
    Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.
    His M; Zelek L; Deschasaux M; Pouchieu C; Kesse-Guyot E; Hercberg S; Galan P; Latino-Martel P; Blacher J; Touvier M
    Eur J Epidemiol; 2014 Feb; 29(2):119-32. PubMed ID: 24519551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men.
    Florvall G; Basu S; Larsson A
    J Gerontol A Biol Sci Med Sci; 2006 Dec; 61(12):1262-6. PubMed ID: 17234819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
    Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
    Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.
    Liem AH; van de Woestijne AP; Roeters van Lennep HW; Zwinderman AH; van der Steeg WA; Jukema JW
    Curr Med Res Opin; 2008 Feb; 24(2):359-64. PubMed ID: 18081989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
    Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
    J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.
    Du Y; Sun H; Li Y; Shi X; Pei D; Qi D; Wang B
    Clin Lab; 2014; 60(8):1295-300. PubMed ID: 25185414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.